Helmy Eltoukhy - Net Worth and Insider Trading
Helmy Eltoukhy Net Worth
The estimated net worth of Helmy Eltoukhy is at least $53 Million dollars as of 2023-03-21. Helmy Eltoukhy is the Co-CEO of Guardant Health Inc and owns about 2,049,238 shares of Guardant Health Inc (GH) stock worth over $53 Million. Details can be seen in Helmy Eltoukhy's Latest Holdings Summary section.
Transaction Summary of Helmy Eltoukhy
Helmy Eltoukhy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Helmy Eltoukhy owns 1 companies in total, including Guardant Health Inc (GH) .
Click here to see the complete history of Helmy Eltoukhy’s form 4 insider trades.
Insider Ownership Summary of Helmy Eltoukhy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GH | Guardant Health Inc | 2020-12-16 | director & Chief Executive Officer |
Helmy Eltoukhy Latest Holdings Summary
Helmy Eltoukhy currently owns a total of 1 stock. Helmy Eltoukhy owns 2,049,238 shares of Guardant Health Inc (GH) as of March 15, 2023, with a value of $53 Million.
Latest Holdings of Helmy Eltoukhy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GH | Guardant Health Inc | 2023-03-15 | 2,049,238 | 25.95 | 53,177,726 |
Holding Weightings of Helmy Eltoukhy
Helmy Eltoukhy Form 4 Trading Tracker
According to the SEC Form 4 filings, Helmy Eltoukhy has made a total of 20 transactions in Guardant Health Inc (GH) over the past 5 years, including 2 buys and 18 sells. The most-recent trade in Guardant Health Inc is the acquisition of 93,052 shares on March 15, 2023, which cost Helmy Eltoukhy around $2 Million.
Insider Trading History of Helmy Eltoukhy
- 1
Helmy Eltoukhy Trading Performance
GuruFocus tracks the stock performance after each of Helmy Eltoukhy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Helmy Eltoukhy is -35.81%. GuruFocus also compares Helmy Eltoukhy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Helmy Eltoukhy within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Helmy Eltoukhy's insider trading performs compared to the benchmark.
Performance of Helmy Eltoukhy
Average Relative Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 4.94 | -35.81 | -59.11 | -46.1 | ||
| Relative Return to S&P 500(%) | 4.19 | -25.89 | -43.83 | -31.96 |
Helmy Eltoukhy Ownership Network
Ownership Network List of Helmy Eltoukhy
Ownership Network Relation of Helmy Eltoukhy
Helmy Eltoukhy Owned Company Details
What does Guardant Health Inc do?
Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company's pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.
Who are the key executives at Guardant Health Inc?
Helmy Eltoukhy is the director & Chief Executive Officer of Guardant Health Inc. Other key executives at Guardant Health Inc include Chief Information Officer Kumud Kalia , SVP & People Amelia Merrill , and Chief Commercial Officer Chris Freeman .
Guardant Health Inc (GH) Insider Trades Summary
Over the past 18 months, Helmy Eltoukhy made 2 insider transaction in Guardant Health Inc (GH) with a net purchase of 197,552. Other recent insider transactions involving Guardant Health Inc (GH) include a net sale of 24,670 shares made by Stanley J Meresman , a net purchase of 201,500 shares made by Amirali Talasaz , and a net sale of 5,125 shares made by Kumud Kalia .
In summary, during the past 3 months, insiders sold 0 shares of Guardant Health Inc (GH) in total and bought 190,052 shares, with a net purchase of 190,052 shares. During the past 18 months, 38,795 shares of Guardant Health Inc (GH) were sold and 399,052 shares were bought by its insiders, resulting in a net purchase of 360,257 shares.
Guardant Health Inc (GH)'s detailed insider trading history can be found in Insider Trading Tracker table.
NAS:GH Insider Transactions
Helmy Eltoukhy Mailing Address
Above is the net worth, insider trading, and ownership report for Helmy Eltoukhy. You might contact Helmy Eltoukhy via mailing address: 2 Barry Lane, Atherton Ca 94027.
